119 related articles for article (PubMed ID: 8067707)
1. Regional DNA content heterogeneity in Wilms' tumor: incidence and potential clinical relevance.
Yildiz I; Jaffe N; Aksoy F; el-Naggar AK
Anticancer Res; 1994; 14(3B):1365-9. PubMed ID: 8067707
[TBL] [Abstract][Full Text] [Related]
2. Role of DNA content analysis and immunohistochemistry in the evaluation of the risk of unfavourable outcome in Wilms' tumours.
Osterheld MC; Caron L; Meagher-Villemure K
Anticancer Res; 2008; 28(2A):751-6. PubMed ID: 18507016
[TBL] [Abstract][Full Text] [Related]
3. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182
[TBL] [Abstract][Full Text] [Related]
4. Decreased E-cadherin expression correlates with higher stage of Wilms' tumors.
Safford SD; Freemerman AJ; Langdon S; Bentley R; Goyeau D; Grundy PE; Skinner MA
J Pediatr Surg; 2005 Feb; 40(2):341-8. PubMed ID: 15750927
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic correlates of loss of heterozygosity in Wilm's tumor: a preliminary analysis.
Grundy P; Telzerow P; Moksness J; Breslow NE
Med Pediatr Oncol; 1996 Nov; 27(5):429-33. PubMed ID: 8926924
[TBL] [Abstract][Full Text] [Related]
6. [Studies on nuclear DNA content in bladder cancers using flow cytometry].
Toyota K
Hokkaido Igaku Zasshi; 1996 Jan; 71(1):45-53. PubMed ID: 8727374
[TBL] [Abstract][Full Text] [Related]
7. DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC)--potential implications for clinical management and treatment decisions.
Hass HG; Schmidt A; Nehls O; Kaiser S
Oral Oncol; 2008 Jan; 44(1):78-85. PubMed ID: 17350326
[TBL] [Abstract][Full Text] [Related]
8. Der(16)t(1;16)(q21;q13) in Wilms' tumor: friend or foe.
Mathew P; Douglass EC; Jones D; Valentine M; Valentine V; Rowe S; Shapiro DN
Med Pediatr Oncol; 1996 Jul; 27(1):3-7. PubMed ID: 8614388
[TBL] [Abstract][Full Text] [Related]
9. DNA ploidy and proliferation heterogeneity in human prostate cancers.
Shankey TV; Jin JK; Dougherty S; Flanigan RC; Graham S; Pyle JM
Cytometry; 1995 Sep; 21(1):30-9. PubMed ID: 8529468
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of gamma catenin in Wilms' tumors.
Basta-Jovanovic G; Gvozdenovic E; Dimitrijevic I; Brasanac D; Jovanovic M; Kalezic N; Baralic I; Radojevic-Skodric S; Arsic D
Fetal Pediatr Pathol; 2008; 27(2):63-70. PubMed ID: 18568994
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of p53 in Wilms' tumors correlates with unfavorable outcome.
Lahoti C; Thorner P; Malkin D; Yeger H
Am J Pathol; 1996 May; 148(5):1577-89. PubMed ID: 8623926
[TBL] [Abstract][Full Text] [Related]
12. DNA ploidy is a valuable predictor for prognosis of patients with resected renal cell carcinoma.
Abou-Rebyeh H; Borgmann V; Nagel R; Al-Abadi H
Cancer; 2001 Nov; 92(9):2280-5. PubMed ID: 11745282
[TBL] [Abstract][Full Text] [Related]
13. [Correlation of cytologic and DNA ploidy evidence and prognosis in childhood Wilm's tumor].
Novik VI; Krasil'nikova LA; Kolygin BA; Punanov IuA
Vopr Onkol; 2004; 50(2):214-8. PubMed ID: 15176226
[TBL] [Abstract][Full Text] [Related]
14. Mutations of the p53 tumor suppressor gene occur infrequently in Wilms' tumor.
Malkin D; Sexsmith E; Yeger H; Williams BR; Coppes MJ
Cancer Res; 1994 Apr; 54(8):2077-9. PubMed ID: 8174107
[TBL] [Abstract][Full Text] [Related]
15. Nuclear accumulation of beta-catenin protein in Wilms' tumours.
Koesters R; Niggli F; von Knebel Doeberitz M; Stallmach T
J Pathol; 2003 Jan; 199(1):68-76. PubMed ID: 12474228
[TBL] [Abstract][Full Text] [Related]
16. DNA quantitation of Wilms' tumour (nephroblastoma) using flow cytometry and image analysis.
Gururangan S; Dorman A; Ball R; Curran B; Leader M; Breatnach F; O'Meara A
J Clin Pathol; 1992 Jun; 45(6):498-501. PubMed ID: 1320635
[TBL] [Abstract][Full Text] [Related]
17. Intratumoral heterogeneity in colorectal carcinoma: trucut sampling for DNA ploidy analysis.
Giovagnoli MR; Giarnieri E; Midiri G; Tesoriere A; Ferraro S; Vecchione A
Anticancer Res; 1999; 19(5C):4577-80. PubMed ID: 10650813
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral regional heterogeneity of DNA ploidy patterns in colorectal carcinomas.
Sasaki K; Kurose A; Uesugi N; Sugai T
Anal Cell Pathol; 1995 Jun; 8(4):323-30. PubMed ID: 7577747
[TBL] [Abstract][Full Text] [Related]
19. The relationship of deoxyribonucleic acid content to conventional prognostic factors in Wilms tumor.
Layfield LJ; Ritchie AW; Ehrlich R
J Urol; 1989 Oct; 142(4):1040-3. PubMed ID: 2552184
[TBL] [Abstract][Full Text] [Related]
20. Association of E2F3 expression with clinicopathological features of Wilms' tumors.
An Q; Wang Y; An R; Li Y; Yao T; Zhai B; Sun X
J Pediatr Surg; 2013 Nov; 48(11):2187-93. PubMed ID: 24210184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
